Treatment Options Overview

Edit Content

BRAND NAME / COMPANY / REIMBURSEMENT AND LOGISTICS PROGRAM (APPROVED BY HEALTH CANADA FOR IBD INDICATIONS)

Remicade®/Janssen/BioAdvance® (CD 2003, UC 2006)
Inflectra®/Pfizer/PfizerFlex (2014)
Renflexis®/Organon/Harmony by Organon(2018)
Avsola®/Amgen/Enliven Services (2020)
Remsima®/Celltrion/Celltrion Connect(2024)

CLASS

Monoclonal antibody
Tumour necrosis factor (TNF) blocking agent

ACTION

IBD causes the immune system to produce an excess amount of TNFα, which causes inflammation. Anti-TNFα is a protein that works to bind TNFα and block inflammation.

           
Edit Content

BRAND NAME / COMPANY / REIMBURSEMENT AND LOGISTICS PROGRAM (APPROVED BY HEALTH CANADA FOR IBD INDICATIONS)

Humira®/AbbVie/AbbVie Care (2004)

Abrilada®/Pfizer/Pfizer Flex (2022)

Amgevita®/Amgen/Enliven (2021)

Hadlima®/Organon/Harmony by Organon™ (2021)

Hulio®/Biocon/My Biocon Biologics (2022)

Hyrimoz®/Sandoz/Xpose® (2021)

Idacio®/Fresenius Kabi/KabiCare® (2021)

Simlandi™/JAMP Pharma/JAMP Care (2022)

Yuflyma®/Celltrion/Celltrion Connect™ (2022)

CLASS

Monoclonal antibody
Tumour necrosis factor (TNF) blocking agent

ACTION

IBD causes the immune system to produce an excess amount of TNFα, which causes inflammation. Anti-TNFα is a protein that works to bind TNFα and block inflammation.

           
Edit Content

BRAND NAME / COMPANY / REIMBURSEMENT AND LOGISTICS PROGRAM (APPROVED BY HEALTH CANADA FOR IBD INDICATIONS)

Stelara®/Janssen/BioAdvance® (CD 2017, UC 2020)

Wezlana/Amgen/Enliven Services (2024)

CLASS

Monoclonal antibody interleukin (IL)-12/23 inhibitor

ACTION

Targets an overactive immune system by blocking two receptors called IL-12 and IL-23. By blocking these receptors, cells are slowed down, which reduces inflammation.

           
Edit Content

BRAND NAME / COMPANY / REIMBURSEMENT AND LOGISTICS PROGRAM (APPROVED BY HEALTH CANADA FOR IBD INDICATIONS)

Entyvio®/Takeda/OnePath® (2015)

CLASS

Monoclonal antibody integrin receptor blocker

ACTION

Blocks integrin α4β7 protein that is found on the surface of white blood cells, thereby reducing intestinal inflammation. Inflammation elsewhere in the body is unaffected.
           
Edit Content

BRAND NAME / COMPANY / REIMBURSEMENT AND LOGISTICS PROGRAM (APPROVED BY HEALTH CANADA FOR IBD INDICATIONS)

Skyrizi®/AbbVie/AbbVie Care (2019)

CLASS

Monoclonal antibody interleukin (IL)-23 inhibitor

ACTION

Targets IL-23 protein receptor, which is one of the proteins responsible for inflammation. Blocking this receptor contributes to reducing inflammation.

           
Edit Content

BRAND NAME / COMPANY / REIMBURSEMENT AND LOGISTICS PROGRAM (APPROVED BY HEALTH CANADA FOR IBD INDICATIONS)

Rinvoq/Abbvie/Abbvie Care (2023)

CLASS

JAK Inhibitor

ACTION

JAKs are intracellular enzymes that activate the body’s immune response causing inflammation. JAK inhibitors block this pathway. Works by attaching to the JAK enzyme to lower its activity and to decrease inflammation in the body.